<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02992249</url>
  </required_header>
  <id_info>
    <org_study_id>CTP004</org_study_id>
    <nct_id>NCT02992249</nct_id>
  </id_info>
  <brief_title>Prospective Evaluation of the ReCellÂ® Autologous Cell Harvesting Device For Specific Compassionate Use Cases</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Avita Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Avita Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective uncontrolled observational study to evaluate clinical outcomes
      following use of the ReCell Autologous Cell Harvesting Device (ReCell) as an adjunct for
      closure (re-epithelialization) as a treatment of life-threatening wounds requiring grafting
      for closure, and associated skin graft donor sites, in patients who lack adequate available
      skin to harvest for conventional grafting. Treatment with the ReCell device may be performed
      as part of a single operative procedure, or multiple staged procedures as deemed clinically
      necessary. Adverse events associated with the use of the ReCell device/cell suspension will
      be documented. Subjects will be followed for 1 year following ReCell treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Wound Healing</measure>
    <time_frame>28 days</time_frame>
    <description>&gt; 95% epithelialization with a contiguous layer of viable epithelium</description>
  </primary_outcome>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Burns</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This is a prospective uncontrolled observational study to evaluate clinical outcomes
        following use of the ReCell Autologous Cell Harvesting Device (ReCell) as an adjunct for
        closure (re-epithelialization) as a treatment of life-threatening wounds requiring grafting
        for closure, and associated skin graft donor sites, in patients who lack adequate available
        skin to harvest for conventional grafting.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient requires treatment of a life-threatening wound requiring grafting.

          -  Patient has inadequate available skin to harvest for conventional skin grafting.

          -  The treating investigator has determined 1) that there is no suitable alternative
             therapy that would be adequate to meet the patient's medical need; and 2) the risk
             associated with use of the ReCell device is no greater than the probable risk from the
             disease or condition.

          -  In the treating investigator's opinion and with consideration of the severity of the
             patient's health status, the patient has the potential to realize benefits from the
             application of the ReCell device.

          -  Patient is hemodynamically stable.

          -  The patient (or legal representative) is able to read and understand instructions and
             give informed consent.

        Exclusion Criteria:

          -  The patient has active infection at the proposed ReCell treatment site.

          -  The patient is unable to follow the protocol.

          -  The patient has a known hypersensitivity to trypsin or Compound Sodium Lactate for
             Irrigation (Hartmann's) solution.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Andrew Quick</last_name>
    <phone>6613679170</phone>
    <email>aquick@avitamedical.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elizabeth Kirshner</last_name>
    <phone>6613679170</phone>
    <email>ekirshner@avitamedical.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of South Alabama Department of Surgery</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36688</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sidney B Brevard, MD MPH FACS</last_name>
    </contact>
    <contact_backup>
      <last_name>Kelley Prutzman, RN BSN</last_name>
      <email>kbose@health.southalabama.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Arizona Burn Center at Maricopa Integrated Health Systems</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85008</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzanne Osborn, RN</last_name>
      <email>Suzanne.Osborn@mihs.org</email>
    </contact>
    <investigator>
      <last_name>Kevin Foster, MD, MBA,FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Diego Regional Burn Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103-8896</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruce M Potenza, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Terry G Curry, R.N.</last_name>
      <email>tcurry@ucsd.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa M McLawhorn, RN, BSN</last_name>
      <email>melissa.m.mclawhorn@medstar.net</email>
    </contact>
    <investigator>
      <last_name>Jeffrey W. Shupp, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Richard M. Fairbanks Burn Center at Eskenazi Health</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Roggy</last_name>
      <email>davidroggy@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Rajiv Sood, MD FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baton Rouge General Regional Burn Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70809</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Spreen, BSN, RN, PCCN</last_name>
      <email>Elizabeth.spreen@brgeneral.org</email>
    </contact>
    <investigator>
      <last_name>Tracee Short, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Walter Reed National Military Medical Center Bethesda</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20889</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ian V Valerio</last_name>
    </contact>
    <contact_backup>
      <last_name>Kelly A Hummer</last_name>
      <email>kelly.a.hummer2.ctr@mail.mil</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jen Levin</last_name>
      <email>jlevin7@partners.org</email>
    </contact>
    <investigator>
      <last_name>Jeremy Goverman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shriner's Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martha Lydon, RN</last_name>
      <email>mlydon@shrinenet.org</email>
    </contact>
    <investigator>
      <last_name>Robert Sheridan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Molnar</last_name>
      <email>jmolnar@wakehealth.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Christopher's Hospital for Children</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Autumn Nanassy, MA</last_name>
      <email>Autumn.Nanassy@tenethealth.com</email>
    </contact>
    <investigator>
      <last_name>Wellington Davis III, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Tennessee Health Science Center</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38103-3409</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Arnold-Ross, MSN, RN, NP-C</last_name>
      <email>aarnoldr@uthsc.edu</email>
    </contact>
    <investigator>
      <last_name>William L. Hickerson, MD, FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>U.S.Army Institute of Surgical Research</name>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234-7767</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victoria Hatem, RN</last_name>
      <email>Victoria.d.hatem.civ@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Reinaldo M Morales, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2016</study_first_submitted>
  <study_first_submitted_qc>December 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2016</study_first_posted>
  <last_update_submitted>January 18, 2018</last_update_submitted>
  <last_update_submitted_qc>January 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

